All news

A 6.5% stake in Xtant Medical (XTNT) is reported alongside a foundation's 5% holding.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

An amended Schedule 13G filing for Xtant Medical Holdings, Inc. (XTNT) reports beneficial ownership for Lawrence W. Lytton and the Lytton-Kambara Foundation as of September 30, 2026. Lytton holds 6.5% of the class, while the Foundation holds 5.0%. Both percentages are calculated based on 140,287,960 common shares outstanding as of August 7, 2026.

Read original source

XTNT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.